• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fulgent Genetics Inc (NQ: FLGT )

    19.43 -2.59 (-11.76%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Fulgent Genetics Inc

    < Previous 1 2 3 4 5 6 7 8 Next >
    Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist
    Fulgent is moving past its pandemic-era business, and that's a good thing. 
    Via The Motley Fool
    Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
    From Fulgent Genetics, Inc.
    Via Business Wire
    Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
    Neither has a traditional business model, but that could be an asset for both. 
    Via The Motley Fool
    2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
    Both are experiencing a bit of a hangover from declining COVID-19-related sales. 
    Via The Motley Fool
    Fulgent Genetics Earnings Perspective: Return On Capital Employed
    Via Benzinga
    Fulgent Genetics: Q1 Earnings Insights
    Via Benzinga
    Preview: Fulgent Genetics's Earnings
    Via Benzinga
    Looking Into Fulgent Genetics's Return On Capital Employed
    Via Benzinga
    Where Fulgent Genetics Stands With Analysts
    Via Benzinga
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting
    From Fulgent Genetics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Fulgent Reports First Quarter 2023 Financial Results
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent Genetics's Return on Invested Capital Insights
    Via Benzinga
    1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings
    Strong core business growth was overshadowed in Q3 by an acquisition. 
    Via The Motley Fool
    Earnings Scheduled For May 5, 2023
    Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion. 
    Via Benzinga
    7 Stocks to Buy to Bag Big-Time Returns in Q2
    If you’re willing to take huge risks, these stocks to buy might yield you massive gains in Q2 – or you could be looking at a tax write-off. 
    Via InvestorPlace
    Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
    From Fulgent Genetics, Inc.
    Via Business Wire
    Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
    From Fulgent, Inc.
    Via Business Wire
    Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
    From Fulgent Genetics, Inc.
    Via Business Wire
    NASDAQ:FLGT Long Term Investor Alert: Investigation of Potential Wrongdoing at Fulgent Genetics, Inc.
    San Diego, CA -- (SBWIRE) -- 02/09/2023 -- An investigation was announced for current long-term investors in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) concerning potential breaches of fiduciary... 
    Via SBWire
    FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    Stocks That Hit 52-Week Lows On Friday
      During Friday's trading, 71 companies set new 52-week lows. 
    Via Benzinga
    Fulgent Expands Board of Directors with Addition of Reggie Groves
    From Fulgent Genetics, Inc.
    Via Business Wire
    Which Is the Better Buy: Vertex or Invitae?
    Is Vertex worth its lofty valuation compared to Invitae? 
    Via The Motley Fool
    My Top 7 Strong Conviction Buys for 2023
    Companies that are down on their luck this year are in strong contention for conviction buys for 2023 as they rebound. 
    Via InvestorPlace
    INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.